Filing Flows › Dare Bioscience (DARE) › Q1 2026 › vs Q4 2025
Dare Bioscience (DARE) Q1 2026 vs Q4 2025 (quarter over quarter)
Dare Bioscience's revenue fell $871K (-85%) from $1.0M in Q4 2025 to $152K in Q1 2026.
Dare Bioscience, Q1 2026: revenue $152K (+500% year over year), net loss $3.0M, operating cash flow −$5.5M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $152K | $1.0M | −$871K | -85% |
| Net loss | $3.0M | $1.4M | $1.6M | +108% |
| Costs & expenses | $3.2M | $2.5M | $657K | +26% |
| Operating costs | $3.2M | $2.5M | $656K | +26% |
| Interest & other, net | $1K | −$30K | $31K | — |
| Research & development | $660K | $622K | $38K | +6% |
| Operating cash sources | $6.5M | −$553K | $7.1M | — |
| Depreciation & amortization | $555K | $534K | $20K | +4% |
| Share-based compensation | $455K | $357K | $98K | +27% |
| Cash used in operations | $5.5M | −$1.4M | $7.0M | — |
| Net loss absorbed | $3.0M | $1.4M | $1.6M | +108% |
| Working capital & other | $3.5M | −$2.0M | $5.5M | — |
Questions
How much did Dare Bioscience's revenue grow quarter over quarter in Q1 2026?
Dare Bioscience's revenue fell $871K (-85%) from $1.0M in Q4 2025 to $152K in Q1 2026.